Safety and Efficacy of Obatoclax Mesylate (GX15-070MS)for the Treatment of Myelodysplastic Syndromes (MDS)

Georgetown University Medical Center, Washington D.C.

Northwest Georgia Oncology Centers, Marietta

Emory University School of Medicine/ Winship Cancer Center, Atlanta

James A. Haley Veterans Hospital, Tampa

Sarah Cannon Cancer Research Institute, Nashville

The West Clinic, Memphis

Michigan State University, Breslin Cancer Center CTO, Lansing

Hematology-Oncology Centers of the Northern Rockies, Billings

University of Chicago, Chicago

Texax Oncology, P.A., Presbyterian/ Mary Crowley Clinical Research Centers, Dallas

Mary Crowley Medical Research Center, Dallas

Arlington Cancer Center, Arlington

MD Anderson Cancer Center (Protocol 2006-0688), Houston

Pacific Oncology, Portland

Stanford University, Stanford

University of Massachusetts Medical Center, Worcester

St. Vincent's Comprehensive Cancer Center, New York

Tom Baker Cancer Centre, Calgary

Maisonneuve-Rosemont Hospital, Montreal

QEII HSC, Halifax

Princess Margaret Hospital, Toronto

Hospital Notre-Dame du Chum, Montreal